Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure

JACC: Heart Failure

Volumn 3, Issue 10, 2015, Pages 751-761

  Salah, Khibar ^a   Kok, Wouter E ^a   Eurlings, Luc W ^b   Bettencourt, Paulo ^c   Pimenta, Joana M ^c   Metra, Marco ^d   Verdiani, Valerio ^e   Tijssen, Jan G ^a   Pinto, Yigal M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c University of Porto   (Portugal)

^d UNIVERSITY OF BRESCIA   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Heart failure; NT proBNP; Prognosis; Renal function; WRF

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; UREA; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK BENEFIT ANALYSIS; UREA BLOOD LEVEL; ACUTE DISEASE; BLOOD; CARDIO-RENAL SYNDROME; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FACTUAL DATABASE; HEART FAILURE; HOSPITAL MORTALITY; KAPLAN MEIER METHOD; KIDNEY FUNCTION TEST; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOMARKERS; CARDIO-RENAL SYNDROME; COHORT STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84943379629     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.05.009     Document Type: Article

References (40)

1. Bueno H., Ross J.S., Wang Y., et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010, 303:2141-2147.
2. Gheorghiade M., Zannad F., Sopko G., et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005, 112:3958-3968.
3. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012, 14:803-869.
4. Mogensen U.M., Ersboll M., Andersen M., et al. Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups. Eur J Heart Fail 2011, 13:1216-1223.
5. Adams K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005, 149:209-216.
6. deSilva R., Nikitin N.P., Witte K.K., et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 2006, 27:569-581.
7. Heywood J.T., Fonarow G.C., Costanzo M.R., Mathur V.S., Wigneswaran J.R., Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 2007, 13:422-430.
8. Ruilope L.M., van Veldhuisen D.J., Ritz E., Luscher T.F. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 2001, 38:1782-1787.
9. Damman K., Jaarsma T., Voors A.A., Navis G., Hillege H.L., van Veldhuisen D.J. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 2009, 11:847-854.
10. Metra M., Nodari S., Parrinello G., et al. Worsening renal function in patients hospitalized for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 2008, 10:188-195.
11. Hillege H.L., Nitsch D., Pfeffer M.A., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006, 113:671-678.
12. Khan N.A., Ma I., Thompson C.R., et al. Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol 2006, 17:244-253.
13. Klein L., Massie B.M., Leimberger J.D., et al. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 2008, 1:25-33.
14. Fonarow G.C., Adams K.F., Abraham W.T., Yancy C.W., Boscardin W.J. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005, 293:572-580.
15. Lee D., Austin P.C., Rouleau J.L., Liu P.P., Naimark D., Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of clinical model. JAMA 2003, 290:2581-2587.
16. Akhter M.W., Aronson D., Bitar F., et al. Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol 2004, 94:957-960.
17. Damman K., Valente M.A., Voors A.A., O'Connor C.M., van Veldhuisen D.J., Hillege H.L. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 2014, 35:455-469.
18. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M. Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail 2006, 12:257-262.
19. Hartmann F., Packer M., Coats A.J., et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 2004, 110:1780-1786.
20. Bettencourt P., Azevedo A., Pimenta J., Friões F., Ferreira S., Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004, 110:2168-2174.
21. Logeart D., Thabut G., Jourdain P., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004, 43:635-641.
22. Metra M., Nordari S., Parrinello G., et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail 2007, 9:776-786.
23. Salah K., Kok W.E., Eurlings L.W., et al. A novel discharge risk model for patients hospitalized for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score. Heart 2014, 100:115-125.
24. Butler J., Forman D.E., Abraham W.T., et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004, 147:331-338.
25. Knight E.L., Glynn R.J., McIntyre K.M., Mogun H., Avorn J. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD). Am Heart J 1999, 138:849-855.
26. Lazzarini V., Bettari L., Bugatti S., et al. Can we prevent or treat renal dysfunction in acute heart failure?. Heart Fail Rev 2012, 17:291-303.
27. Bakris G.L., Weir M.R. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?. Arch Intern Med 2000, 160:685-693.
28. Testani J.M., Kimmel S.E., Dries D.L., Coca S.G. Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail 2011, 4:685-691.
29. Blair J.E., Pang P.S., Schrier R.W., et al. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J 2011, 32:2563-2572.
30. Dries D.L., Exner D.V., Domanski M.J., Greenberg B., Stevenson L.W. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000, 35:681-689.
31. Ather S., Bavishi C., McCauley M.D., et al. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol 2013, 167:1912-1917.
32. McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971, 285:1441-1446.
33. Logeart D., Tabet J.Y., Hittinger L., et al. Transient worsening of renal function during hospitalization for acute heart failure alters outcome. Int J Cardiol 2008, 127:228-232.
34. Felker G.M., Lee K.L., Bull D.A., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011, 364:797-805.
35. Metra M., Davison B., Bettari L., et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure?: the role of congestion and its interaction with renal function. Circ Heart Fail 2012, 5:54-62.
36. Voors A.A., Davison B.A., Felker G.M., et al. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. Eur J Heart Fail 2011, 13:961-967.
37. Testani J.M., Chen J., McCauley B.D., Kimmel S.E., Shannon R.P. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010, 122:265-272.
38. Damman K., Navis G., Voors A.A., et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 2007, 13:599-608.
39. Testani J.M., McCauley B.D., Kimmel S.E., Shannon R.P. Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure. Am J Cardiol 2010, 106:1763-1769.
40. Smilde T.D., van Veldhuisen D.J., Navis G., Voors A.A., Hillege H.L. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 2006, 114:1572-1580.